142 related articles for article (PubMed ID: 26487510)
21. Upregulation of lipopolysaccharide-induced interleukin-10 by prostaglandin A1 in mouse peritoneal macrophages.
Kim HY; Kim JR; Kim HS
J Microbiol Biotechnol; 2008 Jun; 18(6):1170-8. PubMed ID: 18600064
[TBL] [Abstract][Full Text] [Related]
22. Metabolism of prostaglandins A and E in the perfused rabbit lung and the effects of selected inhibitors.
Gross KB; Gillis CN
J Pharmacol Exp Ther; 1976 Sep; 198(3):716-24. PubMed ID: 978471
[TBL] [Abstract][Full Text] [Related]
23. Decreasing acidity in a series of aldose reductase inhibitors: 2-Fluoro-4-(1H-pyrrol-1-yl)phenol as a scaffold for improved membrane permeation.
Chatzopoulou M; Patsilinakos A; Vallianatou T; Prnova MS; Zakelj S; Ragno R; Stefek M; Kristl A; Tsantili-Kakoulidou A; Demopoulos VJ
Bioorg Med Chem; 2014 Apr; 22(7):2194-207. PubMed ID: 24630695
[TBL] [Abstract][Full Text] [Related]
24. Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders.
Srivastava SK; Yadav UC; Reddy AB; Saxena A; Tammali R; Shoeb M; Ansari NH; Bhatnagar A; Petrash MJ; Srivastava S; Ramana KV
Chem Biol Interact; 2011 May; 191(1-3):330-8. PubMed ID: 21354119
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of human malignant melanoma colony-forming cells in vitro by prostaglandin A1.
Bregman MD; Meyskens FL
Cancer Res; 1983 Apr; 43(4):1642-5. PubMed ID: 6572555
[TBL] [Abstract][Full Text] [Related]
26. Prostaglandin A1 metabolism and inhibition of cyclic AMP extrusion by avian erythrocytes.
Heasley LE; Brunton LL
J Biol Chem; 1985 Sep; 260(21):11514-9. PubMed ID: 2995340
[TBL] [Abstract][Full Text] [Related]
27. Inhibitor selectivity between aldo-keto reductase superfamily members AKR1B10 and AKR1B1: role of Trp112 (Trp111).
Zhang L; Zhang H; Zhao Y; Li Z; Chen S; Zhai J; Chen Y; Xie W; Wang Z; Li Q; Zheng X; Hu X
FEBS Lett; 2013 Nov; 587(22):3681-6. PubMed ID: 24100137
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the prostaglandin F synthase activity of human and bovine aldo-keto reductases: AKR1A1s complement AKR1B1s as potent PGF synthases.
Lacroix Pépin N; Chapdelaine P; Fortier MA
Prostaglandins Other Lipid Mediat; 2013 Oct; 106():124-32. PubMed ID: 23747692
[TBL] [Abstract][Full Text] [Related]
29. Novel 3,4-dihydroquinolin-2(1H)-one derivatives as dual inhibitor targeting AKR1B1/ROS for treatment of diabetic complications: Design, synthesis and biological evaluation.
Han Z; Qi G; Zhu J; Zhang Y; Xu Y; Yan K; Zhu C; Hao X
Bioorg Chem; 2020 Dec; 105():104428. PubMed ID: 33161249
[TBL] [Abstract][Full Text] [Related]
30. In Search of Differential Inhibitors of Aldose Reductase.
Balestri F; Moschini R; Mura U; Cappiello M; Del Corso A
Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454074
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and biological evaluation of novel (1-thioxo-1,2,3,4-tetrahydro-β-carbolin-9-yl)acetic acids as selective inhibitors for AKR1B1.
Minehira D; Takeda D; Urata H; Kato A; Adachi I; Wang X; Matsuya Y; Sugimoto K; Takemura M; Endo S; Matsunaga T; Hara A; Koseki J; Narukawa K; Hirono S; Toyooka N
Bioorg Med Chem; 2012 Jan; 20(1):356-67. PubMed ID: 22104435
[TBL] [Abstract][Full Text] [Related]
32. Development of novel pyrazolone derivatives as inhibitors of aldose reductase: an eco-friendly one-pot synthesis, experimental screening and in silico analysis.
Kadam A; Dawane B; Pawar M; Shegokar H; Patil K; Meshram R; Gacche R
Bioorg Chem; 2014 Apr; 53():67-74. PubMed ID: 24607578
[TBL] [Abstract][Full Text] [Related]
33. Stimulation of CFU-f formation by prostaglandin E2 is mediated in part by its degradation product, prostaglandin A2.
Still K; Scutt A
Prostaglandins Other Lipid Mediat; 2001 May; 65(1):21-31. PubMed ID: 11352224
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of steroidal derivatives as selective inhibitors of AKR1B10.
Zhang W; Wang L; Zhang L; Chen W; Chen X; Xie M; Yan G; Hu X; Xu J; Zhang J
Steroids; 2014 Aug; 86():39-44. PubMed ID: 24793566
[TBL] [Abstract][Full Text] [Related]
35. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
Saraswat M; Muthenna P; Suryanarayana P; Petrash JM; Reddy GB
Asia Pac J Clin Nutr; 2008; 17(4):558-65. PubMed ID: 19114390
[TBL] [Abstract][Full Text] [Related]
36. PGE1 and PGA1 bind to Nurr1 and activate its transcriptional function.
Rajan S; Jang Y; Kim CH; Kim W; Toh HT; Jeon J; Song B; Serra A; Lescar J; Yoo JY; Beldar S; Ye H; Kang C; Liu XW; Feitosa M; Kim Y; Hwang D; Goh G; Lim KL; Park HM; Lee CH; Oh SF; Petsko GA; Yoon HS; Kim KS
Nat Chem Biol; 2020 Aug; 16(8):876-886. PubMed ID: 32451509
[TBL] [Abstract][Full Text] [Related]
37. Modification of cysteine residues by cyclopentenone prostaglandins: interplay with redox regulation of protein function.
Oeste CL; Pérez-Sala D
Mass Spectrom Rev; 2014; 33(2):110-25. PubMed ID: 23818260
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs).
Reddy TN; Ravinder M; Bagul P; Ravikanti K; Bagul C; Nanubolu JB; Srinivas K; Banerjee SK; Rao VJ
Eur J Med Chem; 2014 Jan; 71():53-66. PubMed ID: 24275248
[TBL] [Abstract][Full Text] [Related]
39. X-ray structure of the V301L aldo-keto reductase 1B10 complexed with NADP(+) and the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.
Ruiz FX; Cousido-Siah A; Mitschler A; Farrés J; Parés X; Podjarny A
Chem Biol Interact; 2013 Feb; 202(1-3):178-85. PubMed ID: 23295227
[TBL] [Abstract][Full Text] [Related]
40. Inhibition by prostaglandin PGA1 on the multiplication of influenza virus is a dose-dependent effect.
Conti G; Portincasa P; Visalli S; Chezzi C
Virus Res; 2001 May; 75(1):43-57. PubMed ID: 11311427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
